Is it still profitable even with a criminal record? ... Unfair advertising rampant in 'short-form' videos Footage judged to ...
Open enrollment for Medicare plans begins Thursday, allowing people to choose between traditional Medicare and Medicare ...
Ultimately, counting calories is not about punishing the body for eating. It is about understanding what the body needs, ...
Early MASH risk stratification, drug choice, and aligned coverage could improve outcomes, explained Zobair Younossi, MD.
It’s an epic battle today between Novo Nordisk and Eli Lilly in the high-profile and rapidly growing diabetes and obesity ...
Weight loss alone does not explain all of the cardiovascular benefits observed with semaglutide 2.4 mg in the SELECT trial, ...
What happens when a popular weight-loss drug benefit starts costing schools millions? Pennsylvania districts are finding out.
The pharma company’s R&D chief explains how India’s pool of qualified doctors, large patient population and high-quality ...
Kymera Therapeutics (KYMR) eyes pivotal BROADEN2 Phase 2b data for KT-621, a STAT6 degrader in atopic dermatitis—upside vs.
Despite a nearly 600% surge in adolescent GLP-1 prescriptions, the WHO says they may pose critical safety risks to growing bodies.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results